Home » Health » Introducing BRAVE: The Breast Advanced Cancer Center at Mandaya Royal Hospital Puri Tangerang

Introducing BRAVE: The Breast Advanced Cancer Center at Mandaya Royal Hospital Puri Tangerang

Serang (ANTARA) – Mandaya Royal Hospital Puri Tangerang has just launched a breast cancer center called BRAVE (Breast Advanced Cancer Center) on Saturday (2/9), one of which provides surgical services for breast cancer sufferers.

President Director of Mandaya Hospital Group (MHG), dr. Benedictus Widaja, in a written statement on Wednesday, said that BRAVE is a breast cancer center in Indonesia that is designed to treat all types of breast cancer, including luminal A, luminal B, positive HER2 and triple negative breast cancer, both from stage 1 to stage 4 or advanced. .

“The Mandaya BRAVE Breast Cancer Center was created from a collaboration between breast cancer survivors and a team of specialist doctors, where we put forward the lumpectomy method or breast conservation surgery which aims to preserve the patient’s original breast and only remove the tumor and cancer tissue. This can be done because at Mandaya BRAVE we supported by a team of 19 multidisciplinary oncologists and advanced technology such as tissue analysis of frozen section (VC) malignancy, LINAC radiotherapy with radiosurgery technology (high gradient) and combination therapy (chemotherapy, immunotherapy & targeted therapy),” explained dr. Ben Widaja as President Director of Mandaya Hospital Group.

Also read: Mandaya Royal Hospital won an award in Singapore

Consultant doctor for cancer surgery at Mandaya Royal Hospital Puri, dr. Enos H. Siburian, Sp.B (K) Onk, at the event explained that the timeline or time window is crucial, “Recent scientific studies say that patients who have surgery to remove breast tumors before 57-63 days after the first diagnosis have a higher rate of survival rate is high and of course you have to undergo complete therapy both chemotherapy and radiation, fortunately at Mandaya BRAVE there are several professors such as Prof. Aru for chemotherapy and Prof. Soehartati for radiation,” said dr. Enos.

Prof. Dr. dr. Soehartati A. Gondhowiardjo, Sp.Onk.Rad (K) in the same forum added the importance of managing the treatment window for breast cancer patients. “The best time window for breast cancer patients from surgery to chemotherapy to radiation is less than 180 days, if it is below 180 days the survival rate increases significantly,” explained Prof. Soehartati.

Prof. Soehartati added that if a breast cancer patient has completed a series of chemotherapy, then a good time window is less than 28 days to start radiation therapy or irradiation.

Besides being supported by a multidisciplinary team of oncology specialists, Mandaya BRAVE is also equipped with LINAC Elekta Versa HD Radiotherapy Technology, which is the same tool used by the American MD Anderson Cancer Center.

Mandaya also has an anatomical pathology lab and a special clinic that is able to see the chemical properties of tumor or cancer tissue using biomarkers to determine the type of therapy that is suitable, commonly called the CPI examination.

Not only that, Mandaya BRAVE also has molecular examination technology that can detect the possibility of breast cancer recurrence.

At this event it was also explained that there are combination therapies that are widely practiced in parts of the world,

Also read: Mandaya Royal Hospital inaugurates an integrated cancer and radiotherapy center

“Immunotherapy and chemotherapy are innovations in cancer treatment that can increase the body’s immune system’s ability to recognize and kill cancer cells. The combination of immunotherapy and chemotherapy is the first-line treatment for TNBC patients (high aggressive breast cancer cells) and can reduce the risk of death by up to 27 percent,” We continue to innovate in cancer treatment and follow world developments by collaborating medically with a hospital from America, namely the Cleveland Clinic USA,” said Dr. Ben Widaja.

With BRAVE as a center for breast cancer in Indonesia, it is hoped that Indonesian patients will not seek treatment abroad, in addition to reducing treatment costs they are also pursuing the target effective time of therapy before the cancer spreads or becomes an advanced stage, which is under 180 days.

2023-09-06 15:30:28
#Mandaya #Hospital #Tangerang #presents #breast #cancer #surgery #services #ANTARA #News #Banten

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.